Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Neutral

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

OraSure Technologies Inc (OSUR)

Surgical & Medical Instruments & Apparatus

https://www.orasure.com

OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.

220 E FIRST ST
BETHLEHEM, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/17/1992

Market Cap

311,322,653

Shares Outstanding

73,480,000

Weighted SO

73,484,272

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

AKYA --.--%

ATRC --.--%

ATRI --.--%

ICUI --.--%

HAE --.--%

MMSI --.--%

ANGO --.--%

ATR --.--%

NVST --.--%

Beta

0.0940

Last Div

0.0000

Range

3.92-8.45

Chg

0.0550

Avg Vol

1190937

Mkt Cap

311322653

Exch

NASDAQ

Country

US

Phone

610 882 1820

DCF Diff

1.3897

DCF

6.6797

Div Yield

0.0000

P/S

1.1381

EV Multiple

2.7215

P/FV

0.7271

Div Yield %

0.0000

P/E

11.4532

PEG

0.3895

Payout

0.0004

Current Ratio

12.1677

Quick Ratio

10.8418

Cash Ratio

8.9505

DSO

50.8359

DIO

97.1824

Op Cycle

148.0184

DPO

23.0794

CCC

124.9390

Gross Margin

0.4747

Op Margin

0.0557

Pretax Margin

0.1131

Net Margin

0.0988

Eff Tax Rate

0.1085

ROA

0.0580

ROE

0.0641

ROCE

0.0349

NI/EBT

0.8734

EBT/EBIT

2.0296

EBIT/Rev

0.0557

Debt Ratio

0.0271

D/E

0.0296

LT Debt/Cap

0.0241

Total Debt/Cap

0.0288

Int Coverage

5.7048

CF/Debt

5.3159

Equity Multi

1.0951

Rec Turnover

7.1800

Pay Turnover

15.8150

Inv Turnover

3.7558

FA Turnover

5.3926

Asset Turnover

0.5866

OCF/Share

0.9049

FCF/Share

0.8163

Cash/Share

3.6055

OCF/Sales

0.2453

FCF/OCF

0.9021

CF Coverage

5.3159

ST Coverage

31.6100

CapEx Coverage

10.2112

Div&CapEx Cov

10.1957

P/BV

0.7271

P/B

0.7271

P/S

1.1381

P/E

11.4532

P/FCF

5.1428

P/OCF

4.6137

P/CF

4.6137

PEG

0.3895

P/S

1.1381

EV Multiple

2.7215

P/FV

0.7271

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 17, 00:30 Global At-Home Testing Market to Reach USD 11,877.8 Million by 2035 with a CAGR of 4.8%, Driven by Rising Consumer Demand for Self-Diagnostic Tools | Future Market Insights, Inc. Zacks Investment Research Nov 07, 18:50 OraSure Technologies (OSUR) Tops Q3 Earnings and Revenue Estimates Zacks Investment Research Nov 07, 18:50 OraSure Technologies (OSUR) Tops Q3 Earnings and Revenue Estimates Zacks Investment Research Nov 07, 18:50 OraSure Technologies (OSUR) Tops Q3 Earnings and Revenue Estimates

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
1.60 01/08/1998 11/30/-0001 11/30/-0001 11/30/-0001